IRCT20190606043827N1已完成1 期
Effects of Memantine on cognitive impairment in schizophrenic patients
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years(—)
- 性别
- All
入选标准
- •Schizophrenia according to DSM-IV criteria
- •Age 18 to 50 years
- •Receiving common drugs for schizophrenia for at least 3 months before the start of the study (Patients within 3 months of the previous 3 month antipsychotic with a constant dose of 300 to 1000 mg of chlorpromazine (except for clozapine) and a fixed dose of anticholinergic drug of 4 to 8 mg TG Phenidyl)
- •Mental Status Mini Test Score (MMSE) Between 18 and 24
排除标准
- •Dependence and drug addiction
- •History of trauma to the head
- •History of seizure
- •Severe liver and kidney function disorders
- •Severe neurological disorders
- •Receiving drugs that affect cognitive symptoms
研究者
相似试验
招募中
3 期
Evaluation of the effect of Memantine in patients with brain tumorsCognitive Impairment.Mild cognitive impairment, so statedG31.84IRCT20211029052903N1Esfahan University of Medical Sciences70
已完成
3 期
Effect of Memantine on epileptic patientsEpilepsy.Epilepsy and recurrent seizuresIRCT20121110011424N5Tehran University of Medical Sciences60
尚未招募
3 期
The effect of memantine on post-ECT cognition in depressed elderlyIRCT20151122025191N2Iran University of Medical Sciences40
已完成
2 期
Effects of Memantine to improve cognitive disorders caused by ECT in patients with major depressive disorderMajor depressive disorder.Depressive episodeIRCT201506203930N38Shiraz University of Medical Sciences, Vice Chancellor for Research40
已完成
1 期
Effect of Memantine on Cognitive Impairment in Patients With EpilepsyEpilepsyNCT04417543Assiut University100
